Precision medicine in hearing loss

Jason R. Rudman, Christine Mei, Sara E. Bressler, Susan H Blanton, Xue Z Liu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Precision medicine (PM) proposes customized medical care based on a patient's unique genome, biomarkers, environment and behaviors. Hearing loss (HL) is the most common sensorineural disorder worldwide and is frequently caused by a single genetic mutation. With recent advances in PM tools such as genetic sequencing and data analysis, the field of HL is ideally positioned to adopt the strategies of PM. Here, we review current and future applications of PM in HL as they relate to the four core qualities of PM (P4): predictive, personalized, patient-centered, and participatory. We then introduce a strategy for effective incorporation of HL PM into the design of future research studies, electronic medical records, and clinical practice to improve diagnostics, prognostics, and, ultimately, individualized patient treatment. Finally, specific anticipated ethical and economic concerns in this growing era of genomics-based HL treatment are discussed. By integrating PM principles into translational HL research and clinical practice, hearing specialists are uniquely positioned to effectively treat the heterogeneous causes and manifestations of HL on an individualized basis.

Original languageEnglish (US)
JournalJournal of Genetics and Genomics
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Precision Medicine
Hearing Loss
Electronic Health Records
Genomics
Hearing
Biomarkers
Economics
Genome
Mutation
Therapeutics
Research

Keywords

  • Genetics
  • Hearing loss
  • Personalized medicine
  • Precision medicine

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Precision medicine in hearing loss. / Rudman, Jason R.; Mei, Christine; Bressler, Sara E.; Blanton, Susan H; Liu, Xue Z.

In: Journal of Genetics and Genomics, 01.01.2018.

Research output: Contribution to journalArticle

Rudman, Jason R. ; Mei, Christine ; Bressler, Sara E. ; Blanton, Susan H ; Liu, Xue Z. / Precision medicine in hearing loss. In: Journal of Genetics and Genomics. 2018.
@article{367621fc185e42b29c1423bc93b5d769,
title = "Precision medicine in hearing loss",
abstract = "Precision medicine (PM) proposes customized medical care based on a patient's unique genome, biomarkers, environment and behaviors. Hearing loss (HL) is the most common sensorineural disorder worldwide and is frequently caused by a single genetic mutation. With recent advances in PM tools such as genetic sequencing and data analysis, the field of HL is ideally positioned to adopt the strategies of PM. Here, we review current and future applications of PM in HL as they relate to the four core qualities of PM (P4): predictive, personalized, patient-centered, and participatory. We then introduce a strategy for effective incorporation of HL PM into the design of future research studies, electronic medical records, and clinical practice to improve diagnostics, prognostics, and, ultimately, individualized patient treatment. Finally, specific anticipated ethical and economic concerns in this growing era of genomics-based HL treatment are discussed. By integrating PM principles into translational HL research and clinical practice, hearing specialists are uniquely positioned to effectively treat the heterogeneous causes and manifestations of HL on an individualized basis.",
keywords = "Genetics, Hearing loss, Personalized medicine, Precision medicine",
author = "Rudman, {Jason R.} and Christine Mei and Bressler, {Sara E.} and Blanton, {Susan H} and Liu, {Xue Z}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jgg.2018.02.004",
language = "English (US)",
journal = "Journal of Genetics and Genomics",
issn = "1673-8527",
publisher = "Institute of Genetics and Developmental Biology",

}

TY - JOUR

T1 - Precision medicine in hearing loss

AU - Rudman, Jason R.

AU - Mei, Christine

AU - Bressler, Sara E.

AU - Blanton, Susan H

AU - Liu, Xue Z

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Precision medicine (PM) proposes customized medical care based on a patient's unique genome, biomarkers, environment and behaviors. Hearing loss (HL) is the most common sensorineural disorder worldwide and is frequently caused by a single genetic mutation. With recent advances in PM tools such as genetic sequencing and data analysis, the field of HL is ideally positioned to adopt the strategies of PM. Here, we review current and future applications of PM in HL as they relate to the four core qualities of PM (P4): predictive, personalized, patient-centered, and participatory. We then introduce a strategy for effective incorporation of HL PM into the design of future research studies, electronic medical records, and clinical practice to improve diagnostics, prognostics, and, ultimately, individualized patient treatment. Finally, specific anticipated ethical and economic concerns in this growing era of genomics-based HL treatment are discussed. By integrating PM principles into translational HL research and clinical practice, hearing specialists are uniquely positioned to effectively treat the heterogeneous causes and manifestations of HL on an individualized basis.

AB - Precision medicine (PM) proposes customized medical care based on a patient's unique genome, biomarkers, environment and behaviors. Hearing loss (HL) is the most common sensorineural disorder worldwide and is frequently caused by a single genetic mutation. With recent advances in PM tools such as genetic sequencing and data analysis, the field of HL is ideally positioned to adopt the strategies of PM. Here, we review current and future applications of PM in HL as they relate to the four core qualities of PM (P4): predictive, personalized, patient-centered, and participatory. We then introduce a strategy for effective incorporation of HL PM into the design of future research studies, electronic medical records, and clinical practice to improve diagnostics, prognostics, and, ultimately, individualized patient treatment. Finally, specific anticipated ethical and economic concerns in this growing era of genomics-based HL treatment are discussed. By integrating PM principles into translational HL research and clinical practice, hearing specialists are uniquely positioned to effectively treat the heterogeneous causes and manifestations of HL on an individualized basis.

KW - Genetics

KW - Hearing loss

KW - Personalized medicine

KW - Precision medicine

UR - http://www.scopus.com/inward/record.url?scp=85042629303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042629303&partnerID=8YFLogxK

U2 - 10.1016/j.jgg.2018.02.004

DO - 10.1016/j.jgg.2018.02.004

M3 - Article

C2 - 29500086

AN - SCOPUS:85042629303

JO - Journal of Genetics and Genomics

JF - Journal of Genetics and Genomics

SN - 1673-8527

ER -